ANI Pharmaceuticals to Present at September Investor Conferences
ANI Pharmaceuticals will host fireside chats at three September 2026 healthcare and investment conferences, with webcasts accessible through its investor website.
Rhea-AI Summary
ANI Pharmaceuticals (ANIP)/b) announced that President and CEO Nikhil Lalwani and members of the executive leadership team will participate in fireside chats at three September 2026 investor conferences.These are the 2026 Wells Fargo Healthcare Conference on September 10 at 1:30 p.m. ET, the Morgan Stanley 24th Annual Global Healthcare Conference on September 14 at 7:00 a.m. ET, and the H.C. Wainwright 28th Annual Global Investment Conference on September 15 at 12:00 p.m. ET. Live and archived webcasts will be available in the Investors section of the company’s website under Events and Presentations.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 24 | Board appointment | Positive | -1.6% | Henry Gosebruch joined the board while director Shanmugam resigned. |
| Aug 07 | 2Q26 earnings report | Positive | -5.3% | Record quarterly revenue and reaffirmed 2026 guidance were followed by a negative reaction. |
| Jul 24 | 2Q26 results scheduling | Neutral | -1.1% | The company scheduled its second-quarter results discussion for August 7. |
| Jul 16 | Legal appeal announcement | Neutral | -3.3% | ANI announced its intent to appeal rulings in the CG Oncology matter. |
| Jul 13 | Phase 4 clinical data | Positive | -1.2% | SYNCHRONICITY met both co-primary endpoints with statistical significance. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news events were followed by negative 24-hour reactions, including positive earnings and clinical updates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., Sept. 03, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team, will participate in fireside chats at the following upcoming investor conferences:
| Event | 2026 Wells Fargo Healthcare Conference |
| Date | Thursday, September 10, 2026 |
| Time | 1:30 p.m. ET |
| Webcast | Click here |
| Event | Morgan Stanley 24th Annual Global Healthcare Conference |
| Date | Monday, September 14, 2026 |
| Time | 7:00 a.m. ET |
| Webcast | Click here |
| Event | H.C. Wainwright 28th Annual Global Investment Conference |
| Date | Tuesday, September 15, 2026 |
| Time | 12.00 p.m. ET |
| Webcast | Click here |
The live and archived webcasts will also be accessible from the Company’s website at www.anipharmaceuticals.com, in the Investors section under Events and Presentations.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit https://www.anipharmaceuticals.com.
Investor Relations:
Irina Koffler, Vice President, Investor Relations
T: 917-734-7387
E: Irina.koffler@anipharmaceuticals.com
Media Relations:
Argot Partners
T: 212-600-1494
E: ani@argotpartners.com
SOURCE: ANI Pharmaceuticals, Inc.
